TopGum Expects Annualized Revenue Run Rate to Exceed $145 Million in Second Half of 2026
Eyal Shohat, Chief Executive Officer of TopGum • Photo Courtesy of TopGum
TopGum expects its second-half 2026 revenue to reflect an annualized run rate exceeding $145 million as demand from North American customers continues to grow.
Wellness Interviews
♾️
Wellness Interviews ♾️
RAMAT-GAN and SDEROT, Israel, July 13, 2026, (WELLNESS INTERVIEWS) — TopGum Industries expects its revenue in the second half of 2026 to reflect an annualized run rate of more than $145 million, representing an increase of more than 20% compared with the approximately $120 million annualized run rate reported for the second half of 2025.
In a press release, the company reported the expected growth is being driven primarily by expanding business with existing strategic customers and high-growth emerging brands in North America.
TopGum also announced that a strategic North American customer plans to launch a product exclusively developed and manufactured by the company at Costco stores in the United States during the fourth quarter of 2026.
The product uses TopGum's proprietary Gummiceuticals formulation, and the company serves as its exclusive developer and supplier.
According to TopGum, the customer is a rapidly growing probiotics brand that has primarily sold products online. The planned Costco rollout marks the brand's expansion into large-scale retail distribution.
The company estimates the launch will contribute several million dollars in revenue during 2026, with a larger financial contribution expected in 2027.
“Our expected annualized revenue run rate of more than $145 million reflects the strong momentum we continue to build across our business with high-growth brands, particularly in North America. By combining differentiated product development capabilities with a global manufacturing footprint in Israel, Canada, and the U.S., we are well positioned to support growing customer demand and grow alongside our customers. The planned Costco launch by one of our strategic customers is an important milestone and further validates our partnership-driven growth strategy,” said Eyal Shohat, Chief Executive Officer of TopGum.
Founded in 2004, TopGum develops and manufactures gummy dietary supplements for customers worldwide. The company operates manufacturing facilities in Israel, Canada and the United States, employs more than 400 people, and is listed on the Tel Aviv Stock Exchange under the ticker symbol TPGM.
For more information, visit www.tgum.com.
Source: TopGum Industries Ltd.
